This metabolic reprogramming provides tumor cells with the energy they need to proliferate rapidly, and there is evidence that MTFP1 is strongly associated with chemoresistance in lung cancer patients, see Figures 5A,B. This evidence concerns the gene MTFP1 and neoplasm.